|
Market Closed -
Nasdaq
16:00:00 2026-10-14 EDT
|
5-day change | 1st Jan Change | ||
| 30.00 USD | +7.64% |
|
+12.28% | -95.52% |
| 10-09 | Quince Therapeutics Changes Name to IRulya Therapeutics | MT |
| 10-09 | Quince Therapeutics, Inc. Announces Management and Committee Changes, Effective October 8, 2026 | CI |
| Market Cap | 30.51M 27.43M 25.6M 23.2M 43.56M 2.9B 43.83M 307M 120M 1.51B 115M 112M 4.85B | P/E 2026 * |
-3.26x | P/E 2027 * | -4.23x |
|---|---|---|---|---|---|
| Enterprise Value | -65.29M -58.7M -54.78M -49.65M -93.21M -6.21B -93.79M -657M -257M -3.22B -245M -240M -10.37B | EV / Sales 2026 * |
-
| EV / Sales 2027 * | - |
| Free-Float |
99.73% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| IRLA | Delayed | |
CBOE
| IRLA | Real-time |
Last Transcript: IRulya Therapeutics Inc.
| 1 day | +7.64% | ||
| 1 week | +12.28% | ||
| Current month | -3.26% | ||
| 1 month | +4.93% | ||
| 3 months | +55.52% | ||
| 6 months | +20.00% | ||
| Current year | -95.52% |
| 1 week | 25.13 |  | 37 |
| 1 month | 25.13 | | 37 |
| Current year | 15.1 | | 744 |
| 1 year | 15.1 | | 909.98 |
| 3 years | 15.1 | | 909.98 |
| 5 years | 15.1 | | 12,896 |
| 10 years | 15.1 | | 24,396 |
| Manager | Title | Age | Since |
|---|---|---|---|
Brigette Roberts
CEO | Chief Executive Officer | 50 | 2026-10-07 |
John Militello
DFI | Director of Finance/CFO | 52 | 2026-10-07 |
Keith Fandrick
COO | Chief Operating Officer | - | 2026-10-07 |
| Director | Title | Age | Since |
|---|---|---|---|
Brigette Roberts
BRD | Director/Board Member | 50 | 2026-05-17 |
| Director/Board Member | - | 2026-10-07 | |
Leone Patterson
BRD | Director/Board Member | 63 | 2026-10-07 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 5/18/26 | Free | Director | 16,698,162 | - | ||
| 1/23/26 | Free | Chief Financial Officer | 365,000 | 0.6555% | ||
| 1/23/26 | Free | Chief Executive Officer | 1,000,000 | 1.7959% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +7.64% | +12.28% | -92.27% | -84.86% | 28.35M | |
| -2.01% | -7.86% | +60.74% | +70.97% | 70.44B | |
| +3.84% | -11.02% | +8.59% | +57.43% | 50.31B | |
| +3.35% | +1.42% | +11.85% | +40.01% | 47.51B | |
| +0.51% | +1.51% | +27.96% | +31.43% | 42.91B | |
| +2.70% | -3.66% | +307.41% | +547.01% | 40.39B | |
| +0.69% | -3.44% | +9.52% | +96.59% | 39.69B | |
| +0.06% | -2.02% | +11.25% | +43.27% | 30.59B | |
| +0.04% | -8.24% | +38.12% | +1.31% | 26.8B | |
| -0.39% | -6.92% | -13.60% | -14.40% | 22.36B | |
| Average | +1.62% | -3.37% | +36.96% | +78.87% | 37.1B | |
| Weighted average by Cap. | +0.96% | -4.89% | +54.78% | +102.68% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | - |
| Net income | -69.81M -62.77M -58.57M -53.09M -99.67M -6.64B -100M -703M -274M -3.45B -262M -256M -11.09B | -54.47M -48.97M -45.7M -41.42M -77.77M -5.18B -78.25M -548M -214M -2.69B -204M -200M -8.65B |
| Net Debt | -95.8M -86.13M -80.38M -72.85M -137M -9.12B -138M -965M -377M -4.73B -360M -352M -15.22B | -139M -125M -117M -106M -199M -13.27B -200M -1.4B -548M -6.89B -523M -512M -22.14B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-14 | US$30.00 | +7.64% | 26,944 |
| 26-10-13 | US$27.87 | -13.98% | 84,308 |
| 26-10-12 | US$32.40 | +2.11% | 76,907 |
| 26-10-09 | US$31.73 | +8.07% | 138,744 |
| 26-10-08 | US$29.36 | +9.88% | 31,880 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- IRLA Stock
Select your edition
All financial news and data tailored to specific country editions
